作者: Ener Cagri Dinleyici , Zeynel Abidin Yargic
DOI: 10.1586/ERV.09.75
关键词:
摘要: The 27th Annual Meeting of the European Society for Pediatric Infectious Disease (ESPID) was held in Brussels, Belgium, on 8-13 June 2009. Europe's largest pediatric infectious disease congress brought international pediatricians and experts vaccine together. Owing to numerous topics issues that were discussed, this report we summarize current knowledge about pneumococcal conjugate vaccines (PCVs). main covered are seroepidemiology after introduction 7-valent conjugated (PCV7), efficacy immunogenicity a reduced-dose schedule PCV7, effectiveness PCV7 against invasive disease, otitis media related conditions, pneumonia, nasopharyngeal carriage. New studies, including cost-effectiveness currently licensed 10-valent vaccine, which uses protein D from nontypeable Haemophilus influenzae (PHiD-CV) investigational PCVs (investigational 13-valent PCV [PCV13] 11-valent [PCV11]), also presented. Next year, 28th ESPID meeting will be Nice, France, 4-8 2010. We have chance see evaluate, PHiD-CV era, studies new vaccines. With 2015 key millennium development goalonly 5 years away, need accelerate evaluate newcomer order reduce mortality rate among children younger than age by two-thirds.